Pulvinar Neuro LLC
Durham, NC Part of Electromedical Products International, Inc.
- UEI
- M3LMPQ8UECM6
- CAGE
- 7PMG8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Electromedical Products International, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Mineral Wells, TX
SNG9YYLE8FM5
-
Parent
Mineral Wells, TX
SNG9YYLE8FM5
- SAM.gov registration date
- Physical address
- 201 W Main St #207, Durham, NC 27701, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Magnetic Tides, Inc. | El Cerrito, CA | — |
| Soterix Medical Technologies | Woodbridge Township, NJ | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Highland Instruments Inc. | Braintree, MA | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Spark Biomedical Inc. | Friendswood, TX | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Neurotype Inc. | Duluth, MN | — |
About the company
Pulvinar Neuro LLC is a corporate entity registered to receive federal grant awards. It specializes in developing devices and technology related to transcranial alternating current stimulation (tACS) for neuroscience research and potential therapeutic applications.
Pulvinar Neuro has received multiple federal grants from the National Institutes of Health, focusing on advancing tACS technology. One award funded the development of a higher-powered tACS device, XCSITE HPTACS, for treating substance use disorders. The project involved modifying existing equipment, preclinical testing, and a pilot feasibility study in patients. Another major grant supports the XCSITE 300 platform, a cloud-enabled closed-loop tACS system that adapts stimulation based on real-time EEG readings. Plans include evaluating the XCSITE 300 for in-clinic and at-home use in treating depression through double-blind clinical trials. Pulvinar Neuro has also received funding for the XCSITE 200, a cloud-based platform enabling multi-site tACS research studies. Through these grants, primarily from NIDA and NIMH, Pulvinar Neuro aims to advance tACS capabilities for targeted neural circuit modulation and develop potential new treatments for neuropsychiatric conditions like substance abuse and depression.
Quick answers
Is Pulvinar Neuro LLC registered in SAM.gov?
Yes. Pulvinar Neuro LLC's SAM.gov registration is active through November 25, 2026.
How does Pulvinar Neuro LLC rank among federal contractors?
Pulvinar Neuro LLC's parent company, Electromedical Products International, Inc., ranked #31 in PSC 8520, #32 in NAICS 334510 and #81 in PSC 85 in FY2025.
What is Pulvinar Neuro LLC's most recent federal award?
Pulvinar Neuro LLC's most recent federal grant award is Development and evaluation of a higher power tacs device for the treatment of SUD (R43DA054848), from National Institute on Drug Abuse (NIH), on September 1, 2021.
On GovTribe
See Pulvinar Neuro LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors